Othera Pharmaceuticals (OT-730 drug) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Othera Pharmaceuticals (OT-730 drug) General Information

Description

Eye drop drug for treating glaucoma disease. The drug consists of a small molecule oculoselective beta-blocker for reducing the elevated intraocular pressure associated with glaucoma disease. Beta-blockers as a class are among the most prescribed drugs for glaucoma.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 730 Springdale Drive
  • Exton, PA 19341
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • 730 Springdale Drive
  • Exton, PA 19341
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Othera Pharmaceuticals (OT-730 drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Othera Pharmaceuticals (OT-730 drug)‘s full profile, request access.

Request a free trial

Othera Pharmaceuticals (OT-730 drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Othera Pharmaceuticals (OT-730 drug)‘s full profile, request access.

Request a free trial

Othera Pharmaceuticals (OT-730 drug) FAQs

  • Where is Othera Pharmaceuticals (OT-730 drug) headquartered?

    Othera Pharmaceuticals (OT-730 drug) is headquartered in Exton, PA.

  • What industry is Othera Pharmaceuticals (OT-730 drug) in?

    Othera Pharmaceuticals (OT-730 drug)’s primary industry is Buildings and Property.

  • Is Othera Pharmaceuticals (OT-730 drug) a private or public company?

    Othera Pharmaceuticals (OT-730 drug) is a Private company.

  • What is the current valuation of Othera Pharmaceuticals (OT-730 drug)?

    The current valuation of Othera Pharmaceuticals (OT-730 drug) is .

  • What is Othera Pharmaceuticals (OT-730 drug)’s current revenue?

    The current revenue for Othera Pharmaceuticals (OT-730 drug) is .

  • Who are Othera Pharmaceuticals (OT-730 drug)’s investors?

    Othera Pharmaceuticals has invested in Othera Pharmaceuticals (OT-730 drug).

  • When was Othera Pharmaceuticals (OT-730 drug) acquired?

    Othera Pharmaceuticals (OT-730 drug) was acquired on 30-Dec-2009.

  • Who acquired Othera Pharmaceuticals (OT-730 drug)?

    Othera Pharmaceuticals (OT-730 drug) was acquired by Novelion Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process